Directly Administered Antiretroviral Therapy for HIV-Infected Individuals in Opioid Treatment Programs: Results from a Randomized Clinical Trial

• Gregory M. Lucas ,

  * E-mail: glucas@jhmi.edu

  Affiliation Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Bernadette Anna Mullen,

  Affiliation Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Noya Galai,

  Affiliation Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland and the Department of Statistics, University of Haifa, Haifa, Israel

  ⨯
• Richard D. Moore,

  Affiliation Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Katie Cook,

  Affiliation Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Mary E. McCaul,

  Affiliation Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Sheldon Glass,

  Affiliation Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Krisann K. Oursler,

  Affiliation Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Maryland School of Medicine and the Department of Veterans Affairs Medical Center, Baltimore, Maryland, United States of America

  ⨯
• Cynthia Rand

  Affiliation Division of Pulmonary and Critical Care, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯